/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
EUR/USD
-1.07%
Natural Gas
-2.67%
Gold
-2.58%
BTC
-1.36%
ETH
-0.19%
SPX
-1.03%
VIX
-2.14%
Economic Calendar
EUR/USD
-1.07%
Natural Gas
-2.67%
Gold
-2.58%
BTC
-1.36%
ETH
-0.19%
SPX
-1.03%
VIX
-2.14%
Economic Calendar
BTC
-1.36%
ETH
-0.19%
XRP
-0.39%
ADA
-0.81%
SOL
-1.70%
Review
Review
Review
Bike desks help Mexican students learn while burning calories
7 minutes ago
WHO report on Ukraine health emergency sparks U.S., Russia row
7 minutes ago
ECB’s Visco says caution warranted in policy tightening
9 minutes ago
Japan PM Kishida fires aide over same-sex couple outburst
39 minutes ago
Why are Peruvian politics such a mess? Inside the halls of its Congress
39 minutes ago
Brazil sinks rusting old aircraft carrier in the Atlantic
39 minutes ago
ETH Bulls in Need of Positive Zhejiang Testing News to Retarget $1,700
about 8 hours ago
XRP Bears to Target Sub-$0.40 on SEC v Ripple Silence and Fed Fear
about 8 hours ago
ADA Price Prediction: IOHK Weekly Update Leaves $0.420 in View
about 9 hours ago
BTC Fear & Greed Index Stays Greedy Despite a Bearish BTC
about 11 hours ago
If You Did Not Hear This Coming, You Had Better Get Your Ears Checked
about 16 hours ago
Deepening Bearish Sentiment in Natural Gas Takes it to New Lows
about 19 hours ago
Quick Links
:
Forecasts
Economic Calendar
Crypto
Commodities
FXTM Academy
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
NVAX
profile
Novavax, Inc.
Follow
NVAX
(
Nasdaq - US
)
Closed
11.25
-0.76 (-6.37%)
in
:
usd
•
As of: Feb 03, 2023 15:59
UTC -5
Open
11.70
High
12.25
Low
11.18
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Novavax, Inc.
CEO
Stanley C. Erck
Headquarters
21 firstfield road
gaithersburg, md 20878, united states
Auditor
Ernst & Young LLP
Employees
1,541
Share Holders
133
Website
www.novavax.com
Industry
biotechnology
Sector
health technology
Company Overview
Novavax, Inc. is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. The company is also developing proprietary immune stimulating saponin-based adjuvants, namely Matrix-M, which already enhanced immune responses and were well-tolerated in multiple studies.?Novavax developed its own coronavirus vaccine NVX-CoV2373. The company is currently marketing two versions of NVX-CoV2373, one marketed in partnership with the Serum Institute of India under the trade name Covovax and another version produced by Novavax and marketed under the trade name Nuvaxovid.?Novavax developed NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate with Matrix M adjuvant for senior patients aged 65 years and above.?ResVax a respiratory syncytial virus vaccine is being developed to protect infants by immunizing mothers against the disease. Novavax is discussing the opportunity to bring ResVax to the market globally with the help of commercial partners.
Novavax, Inc.
Statistics
Valuation Measures
Market Capitalization
2
882.73M
Enterprise Value
29.46M
Enterprise Value/EBITDA
(ttm)
-0.02
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
N/A
Price to Sales
(ttm)
0.51
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
48.22%
Operating Margin
(ttm)
-71.59%
Profit Margin
(ttm)
-162.37%
Return on Equity
(ttm)
N/A
Return on Invested Capital
(ttm)
3464.77%
Return on Assets
(ttm)
-51.33%
Income Statement
Revenue
(ttm)
1.85B
Revenue Per Share
(ttm)
23.52
Gross Profit
(ttm)
1.13B
EBITDA
(ttm)
3
-1.20B
Net Income Avi to Common
(ttm)
-1.32B
Diluted EPS
(ttm)
-17.30
Share Statistics
Beta (5Y Monthly)
1.73
52-Week Change
-87.41%
S&P500 52-Week Change
-8.09%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
78.50M
Dividend Yield
0.00%
Float
4
76.86M
%
Held by Insiders
2.10%
%
Held by Institutions
45.70%
Balance Sheet
Total Cash
(mrq)
1.29B
Total Cash Per Share
(mrq)
16.45
Total Debt
(mrq)
438.09M
Total Debt/Equity
(mrq)
-77.40%
Current Ratio
(mrq)
1.06%
Quick Ratio
(mrq)
1.01%
Book Value Per Share
(mrq)
-7.21
Cash Flow
Operating Cash Flow Per Share
(ytd)
-3.81
Free Cash Flow
(ytd)
-364.15M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker